Cipla Pharmaceuticals Limited - Company Profile

Q: Who are the current directors of Cipla Pharmaceuticals Limited?

The current directors of Cipla Pharmaceuticals Limited are Anil Kumar Choudhary, Dinesh Ramniranjan Jain, Rahul Verma, Naveen Kapil, Rajendra Kumar Chopra, Raju Sunil Mistry.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2019.

2019 Mumbai, Maharashtra, India Active

Last Updated: December 20, 2025

Access Report

About Cipla Pharmaceuticals Limited

Cipla Pharmaceuticals Limited, a active public limited company, was established on 19 November 2019 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH2019PLC333266. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹190.00 Cr and a paid-up capital of ₹170.00 Cr.

It upholds a compliant status. Employing 61 professional, Its leadership includes Dinesh Ramniranjan Jain (Director), Naveen Kapil (Managing Director), Rajendra Kumar Chopra (Director). Past directors included Sanjay Bhanushali Surendra, Geena Malhotra, Anisha Naresh Udeshi. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Tower A, 1St Floor, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel,, Mumbai, Maharashtra, 400013.

Company Details

CIN/LLPIN
U24239MH2019PLC333266
Registration Number
333266
Incorporation Date
19 November 2019
Authorized Capital
₹190.00 Cr
Paid-Up Capital
₹170.00 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 190.00 Cr as on 20-12-2025
Paid Up Capital ₹ 170.00 Cr as on 20-12-2025
Company Age 6 Year, 7 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** 128.94% (FY 2023)
Profit Growth **** -1.62% (FY 2023)
Ebitda **** -16.82% (FY 2023)
Net Worth 140.13% (FY 2023)
Total Assets **** 131.94% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Cipla Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Cipla Pharmaceuticals Limited?

Current Directors

Name	Designation	Appointment Date	Status
Dinesh Ramniranjan Jain	Director	19 Nov 2019	Current
Naveen Kapil	Managing Director	13 Mar 2025	Current
Rajendra Kumar Chopra	Director	19 Nov 2019	Current
Raju Sunil Mistry	Additional Director	23 Jul 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	01 Jul 2021	Past
Pramod Abcsdd	Additional Director	27 Sep 2021	Past
Pramod Abcsdd	Additional Director	27 Sep 2021	Past
Pramod Abcsdd	Cfo(Kmp)	-	Past
Pramod Abcsdd	Cfo(Kmp)	-	Past
Pramod Abcsdd	Company Secretary	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cipla Pharmaceuticals.

Cipla Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 128.94% increase. The company also saw a slight decrease in profitability, with a 1.62% decrease in profit. The company's net worth Soared by an impressive increase of 140.13%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

128.94%

*******

Revenue from Operations

*******

Total Assets

*******

131.94%

*******

Profit or Loss

*******

-1.62%

*******

Net Worth

*******

140.13%

*******

EBITDA

*******

-16.82%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cipla Pharmaceuticals?

In 2024, Cipla Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Cipla Pharmaceuticals?

Cipla Pharmaceuticals has a workforce of 61 employees as of Apr 07, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Cipla Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cipla Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cipla Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

Progress on Cipla Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
30 Sep 2025
Director Appointment

Progress on Raju Sunil Mistry was appointed as a Additional Director was appointed as a Additional Director on 23 Jul 2025 & has been associated with this company since 11 months 7 days . was documented.
23 Jul 2025
Balance Sheet

Cipla Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
31 Mar 2025
Director Appointment

The activity Naveen Kapil was appointed as a Managing Director was appointed as a Managing Director on 13 Mar 2025 & has been associated with this company since 1 year 3 months . was completed.
13 Mar 2025
Director Appointment

Progress on Anil Kumar Choudhary was appointed as a CFO was appointed as a CFO on 24 Aug 2023 & has been associated with this company since 2 years 10 months . was documented.
24 Aug 2023
Director Appointment

Progress on Rahul Verma was appointed as a Company Secretary was appointed as a Company Secretary on 09 May 2020 & has been associated with this company since 6 years 1 month . was documented.
09 May 2020

Explore recent activity and updates - View Recent Activity